We protect your health through science
Investigación
Leishmaniasis and Chagas Disease
Publicaciones destacadas
Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019
Villalón P, Sáez-Nieto JA, Rubio-López V, Medina-Pascual MJ, Garrido N, Carrasco G, Pino-Rosa S, Valdezate S. (2021). Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019. Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2295-2303
PUBMED DOICharacterization of Trichuris muris secreted proteins and extracellular vesicles provides new insights into host-parasite communication.
Eichenberger RM, Talukder MH, Field MA, Wangchuk P, Giacomin P, Loukas A, Sotillo J. Characterization of Trichuris muris secreted proteins and extracellular vesicles provides new insights into host-parasite communication. J Extracell Vesicles. 2018 Jan 21;7(1):1428004.
PUBMED DOIContent with Investigacion .
-
Isabel de Fuentes Corripio
Jefa de Unidad, Investigador Titular OPIS
-
David Carmena Jiménez
Investigador Doctor distinguido
-
Aly Salimo Omar Muadica
Becario pre-doctoral
-
Marta Hernández de Mingo
Colaborador I+D+I
-
Begoña Bailo Cardoso
Técnico de Laboratorio
-
María Aguilera
Técnico de laboratorio
-
David González Barrio
Investigador contratado
List of staff
Información adicional
The Leishmaniasis and Chagas Disease Unit supports the National Health System through a multidisciplinary approach that includes the development and validation of diagnostic tests, the molecular characterization of parasites, molecular epidemiology, field studies, as well as experimental research into new therapeutic and prophylactic approaches for their control.
The laboratory has extensive experience in the characterization of the cellular and humoral immune response of leishmaniasis and post-treatment monitoring, as well as in asymptomatic individuals and in experimental animal models. The laboratory also contributes to immunological studies of the pathogenesis of leishmaniasis under immunosuppressive conditions (HIV/Leishmania co-infection, malnutrition, immunosuppressive treatment...). The laboratory has been a WHO Collaborating Center for Leishmaniasis since 1997, providing technical support to the various research and training activities of the WHO and participating in the evaluation of outbreaks of human leishmaniasis in endemic countries.
The laboratory also participates in the evaluation of prognostic markers for the evolution of T. cruzi infection and vertical (transplacental) transmission, an important public health problem in our country. It also carries out studies on the pharmacokinetics of drugs against Chagas disease.